The Latest

Landmark Transatlantic Trial for Children with High-Risk Neuroblastoma Funded by Parent-Led Charities

In a landmark in pediatric oncology research, children with high-risk neuroblastoma across Europe and North America will be treated together for the first time, following the award of $1.3M to fund a new transatlantic clinical trial led by Dr. Yael Mossé of Children’s Hospital of Philadelphia and Dr. Dominique Valteau-Couanet of Gustave Roussy in Paris,…

Rare Brain Tumors in Kids

  Brain and spinal cord tumors, also known as central nervous system (CNS) tumors, are the most common type of solid tumors affecting children. Brain tumors make up about 15% of pediatric cancers, and are the second most commonly diagnosed cancer in children and now, the deadliest type of childhood cancer, ahead of leukemia. The…

TWiPO #76 – Interview with Rebecca Johnson & Becca Jacobsen

Guest host Dr. Ryan Roberts welcomes Rebecca Johnson and Becca Jacobsen to a conversation about the benefits and contributions of AYA (Adolescent/Young Adult) psycho-social support programs which serve the needs and challenges within this demographic of cancer patients and survivors. Ryan D. Roberts, MD, PhD, is a physician for the Division of Hematology and Oncology…

TWiPO#75 – Interview with Dr. Robert Wechsler-Reya

Host, Dr. Timothy Cripe from Nationwide Children’s Hospital, along with co-host – Dr. Nilay Shah, are joined by Dr. Robert Wechsler-Reya from Sanford Burnham Prebys in San Diego, CA. They discuss Dr. Wechsler-Reya’s work including the process, benefits, and limitations of tumor models in mice, as well as research behind the humanized mouse model. They…

TWiPO #74 – Interview with Abby Rosenberg

TWIPO Host Tim Cripe, alongside co-hosts Ryan Roberts and Lisa Humphrey, engage in an insightful conversation with guest Abby Rosenberg, Director, Palliative Care and Resilience Research at Seattle Children’s Research Institute. Rosenberg, with Seattle Children’s colleague, Yi-Frazier, developed a promising systematic intervention program called PRISM (Promoting Resilience in Stress Management) for teens and young adults…

Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma

FOR IMMEDIATE RELEASE   Clinical Trial Harnesses Power of Natural Killer Cells to Treat Neuroblastoma   Nov 13, 2018 New York City— Researchers have made rapid advances in understanding how to manipulate the immune system safely to destroy cancer cells. Adoptive transfer of haploidentical natural killer (NK) cells has shown promise as a treatment option…

Transatlantic Clinical Trial For Children With Neuroblastoma is Open For Enrollment in the U.K. – Soon to Open in The U.S. and Germany

June 11, 2018 FOR IMMEDIATE RELEASE TRANSATLANTIC CLINICAL TRIAL FOR CHILDREN WITH NEUROBLASTOMA IS OPEN FOR ENROLLMENT IN THE U.K. – SOON TO OPEN IN THE U.S. AND GERMANY Charities Collaborate to Initiate International Phase 1 Clinical Trial  for Children with Neuroblastoma   June 1, 2018 – NEW YORK – Solving Kids’ Cancer has partnered with Band…

The Childhood Cancer STAR Act has been signed!

The Childhood Cancer Star Act of 2017 is now law, a landmark moment for the childhood cancer community.  You can find a summary of the new law, signed on June 5, 2018 by President Trump, below. The passage of the STAR Act was a true community effort that involved years of patience, hard work, and…

Solving Kids’ Cancer 2018 Spring Celebration

Solving Kids’ Cancer Closer to Cures Honoring Usman “Oz” Azam, MD President & CEO Tmunity  Therapeutics Thomas Gad Founder & President Y-mAbs Therapeutics with  Master of Ceremonies, Mikhail “Doctor Mike” Varshavski, World’s Most Followed Doctor Hosted by Gabby & Gianpaolo, De Felice, Lindy Gad, Angelina Jolin, Jan Planit, Frederique van der Wal, and Bonnie Young…